$24.05
-0.21[-0.87%]
At close: May 10
$24.05
0[0.00%]
After Hours: 4:00PM EDT
Alkermes
(NASDAQ:ALKS)Overview Rating
Speculative
Alkermes Stock (NASDAQ:ALKS), Quotes and News Summary
Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
| Open | $24.350 |
| Close | $24.050 |
| Volume / Avg. | 1.002M / 2.068M |
| Day Range | 24.040 - 24.460 |
| 52 Wk Range | 22.010 - 33.710 |
| Market Cap | $4.070B |
| P/E Ratio | 7.223 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 11.67% |
| Days to Cover | 6.82 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alkermes (ALKS) stock?
You can purchase shares of Alkermes (NASDAQ: ALKS) through any online brokerage.
Who are Alkermes's (ALKS) competitors?
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Alkermes (ALKS) stock?
The latest price target for Alkermes (NASDAQ: ALKS) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 35.00 expecting ALKS to rise to within 12 months (a possible 45.53% upside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Alkermes (ALKS)?
The stock price for Alkermes (NASDAQ: ALKS) is $24.05 last updated May 10, 2024 at 4:00 PM EDT.
Does Alkermes (ALKS) pay a dividend?
There are no upcoming dividends for Alkermes.
When is Alkermes (NASDAQ:ALKS) reporting earnings?
Alkermes’s Q2 earnings are confirmed for Wednesday, July 24, 2024.
Is Alkermes (ALKS) going to split?
There is no upcoming split for Alkermes.
What sector and industry does Alkermes (ALKS) operate in?
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.